Published online Nov 21, 2015. doi: 10.3748/wjg.v21.i43.12510
Peer-review started: June 6, 2015
First decision: July 10, 2015
Revised: July 28, 2015
Accepted: September 14, 2015
Article in press: September 15, 2015
Published online: November 21, 2015
Core tip: With the availability of new direct-acting antivirals for hepatitis C virus (HCV), some people think that eradication of HCV may be only one step away. There are a number of issues that need to be overcome to win the fight against HCV. Although the cost of HCV treatment is reduced for certain countries, cost remains a big problem for low and middle income countries for the treatment of a large number of patients. In low income countries, 47% of blood transfusions are from laboratories with no quality management in place. There is a lack of knowledge and awareness about HCV among healthcare providers, policy makers, general public, and at risk populations.